DR REDDYS LABORATORIES LTD

Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.

RDY | NYSE

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD
Website:: https://www.drreddys.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dr. Reddy's Laboratories Ltd., established in 1984, is an integrated global pharmaceutical company. The firm develops, manufactures, and markets a wide range of pharmaceutical products. Its core business segments include Global Generics, Pharmaceutical Services, and Active Ingredients (PSAI). The company's portfolio comprises over 190 medications, 60 active pharmaceutical ingredients (APIs), diagnostic kits, and products in critical care and biotechnology. Dr. Reddy's focuses on key therapeutic areas such as gastrointestinal, cardiovascular, pain management, oncology, neurology, and anti-infectives. Driven by the purpose "Good Health Can't Wait," the company aims to provide affordable and innovative medicines to patients worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DR REDDYS LABORATORIES LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DR REDDYS LABORATORIES LTD

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DR REDDYS LABORATORIES LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Armata Pharmaceuticals, Inc. Developing bacteriophage therapeutics for antibiotic-resistant infections.	United States of America	ARMP
AroCell AB Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.	Sweden	AROC
ArriVent BioPharma, Inc. A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.	United States of America	AVBP
ARROWHEAD PHARMACEUTICALS, INC. Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.	United States of America	ARWR
ARS Pharmaceuticals, Inc. Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.	United States of America	SPRY
ARTELO BIOSCIENCES, INC. Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.	United States of America	ARTL
Artiva Biotherapeutics, Inc. Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.	United States of America	ARTV
Ascelia Pharma Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.	Sweden	ACE
Ascendis Pharma A/S Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.	United States of America	ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.	United States of America	AAPG